Abstract
Objective: To study the effect of Baduanjin with acute coronary syndrome after percutaneous coronary intervention. Method: 60 patients with acute coronary syndrome after stenting were randomly divided into two groups (treatment group and control group). The treatment group received medication and Baduanjin treatment, while the control group received medication treatment only 6 months after, all patients received six minutes’ walk test and Seattle Angina Questionnaire. Result: After 6 months, the treatment group was a significant difference compared with the control group on the 6MWT and SAQ(P<0.05). Conclusion: Baduanjin can improve the cardiopulmonary function and quality of life of acute coronary syndrome after PCI.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
